Stay updated on Galegenimab in Geographic Atrophy AMD: Clinical Trial
Sign up to get notified when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.

Latest updates to the Galegenimab in Geographic Atrophy AMD: Clinical Trial page
- Check4 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4. This reflects a small update to the site's rendering system.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a software version update. No study information or content on the page appears to be altered.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page now shows an updated Revision tag: v3.6.2, replacing v3.6.0, indicating a software update to the site’s interface.SummaryDifference0.0%

- Check40 days agoChange DetectedNo changes were detected on the page; the study details remain as published.SummaryDifference0.0%

- Check47 days agoChange DetectedRecruitment has been closed for the study, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, while the Intervention/Treatment label is adjusted and a Revision note updated.SummaryDifference0.3%

- Check54 days agoChange DetectedRevision: v3.5.5 is now shown, replacing v3.5.4. This indicates a minor platform update with no changes to the study data or main page content.SummaryDifference0.0%

Stay in the know with updates to Galegenimab in Geographic Atrophy AMD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.